Home Covid News and Updates Dr Reddy’s releases crucial information regarding 2DG drug

Dr Reddy’s releases crucial information regarding 2DG drug

by Vaishali Sharma
Dr Reddy's

Dr Reddy’s, on Wednesday released an important information regarding 2-Deoxy-D-glucose, a drug developed by INMAS, a DRDO lab in collaboration with Dr Reddy’s, for the treatment of Covid-19.

  • Emergency use approval has been granted in India for anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2DG) developed by INMAS, a lab of the DRDO, in collaboration with Dr Reddy’s laboratories.
  • 2DG is an oral anti-viral drug that can be administered only upon prescription to hospitalised moderate to severe Covid-19 patients as adjunct (add on) therapy along with existing standard of care.
  • 2DG has not yet been launched into the market. Price per sachet has not yet been announced.
  • Commercial launch and supply of 2DG to major Government and private hospitals is expected to commence in mid-June. Price is being determined with a view to making it accessible and affordable to as many patients as possible, and will be announce soon.
  • Please beware of agents selling spurious or illegal products in the name of 2DG.
  • Please beware of unverified messages relating to 2DG circulating on Social media and Whatsapp.

You may also like